Institut Claudius Regaud ( Site 0051)

Toulouse, Haute-Garonne 31059

0 studies enrolling now · 1 studies all time

What they study most

Lymphoma, Solid Tumors

Studies at this site

• Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001) — Completed